SEC Form 4 · accession 0000919574-15-008284
MADRIGAL PHARMACEUTICALS, INC. · MDGL
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Bruce Kovner
Director · 10% Owner
Period of report
Nov 13, 2015
Accepted (ET)
Nov 17, 2015 · 5:08 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001157601
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F4 | Nov 13, 2015 | S | 507,788 | $0.4324 | D | 1,817,255 | I | By CxSynta LLC |
| Common StockF2,F4 | Nov 16, 2015 | S | 15,530 | $0.4352 | D | 1,801,725 | I | By CxSynta LLC |
| Common StockF3,F4 | Nov 17, 2015 | S | 700,618 | $0.422 | D | 1,101,107 | I | By CxSynta LLC |
| Common Stock | holding | — | — | — | 3,092,677 | D | ||
| Common StockF5 | holding | — | — | — | 2,279,146 | I | By Wife | |
| Common StockF6 | holding | — | — | — | 11,399,464 | I | By KFO Holdings LLC | |
| Common StockF7 | holding | — | — | — | 5,460,000 | I | By OB Select Opportunities, LLC | |
| Common Stock | holding | — | — | — | 4,000,000 | I | By Kovner 2015-A Investment Trust | |
| Common Stock | holding | — | — | — | 3,100,000 | I | By Kovner 2012 Family Trust B |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1This constitutes the weighted average sale price. The prices range from $0.43 to $0.4498. The Reporting Person will provide upon request by the Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- F2This constitutes the weighted average sale price. The prices range from $0.43 to $0.4497. The Reporting Person will provide upon request by the Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- F3This constitutes the weighted average sale price. The prices range from $0.4002 to $0.4388. The Reporting Person will provide upon request by the Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- F4These shares are owned directly by CxSynta LLC and indirectly by the Reporting Person as chairman and sole shareholder of Caxton Corporation, the managing member of CxSynta LLC. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of the beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.
- F5These securities are owned by the wife of the Reporting Person and her estate planning vehicles.
- F6These shares are owned directly by KFO Holdings LLC and indirectly by the Reporting Person as chairman and sole shareholder of Caxton Corporation, the manager of KFO Holdings LLC. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.
- F7These shares are owned directly by OB Select Opportunities, LLC and indirectly by the Reporting Person as chairman and sole shareholder of Caxton Corporation, the manager of OB Select Opportunities, LLC. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.